Fertiglobe (FERTIGLB) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
23 Nov, 2025Executive summary
Q2 2025 revenue reached $566 million, up 14% year-over-year, with H1 2025 revenue at $1.26 billion, a 20% increase year-over-year, despite gas supply disruptions in Egypt and operational turnarounds in the UAE.
Adjusted EBITDA for Q2 2025 was $176 million, up 26% year-over-year; H1 2025 adjusted EBITDA was $437 million, up 36% year-over-year.
Adjusted net profit attributable to shareholders was $12 million in Q2 2025, up 68% year-over-year, and $85 million for H1 2025, down 18% due to prior year FX gain.
Management proposed H1 2025 dividends of at least $100 million, with total shareholder returns of $131 million including share buybacks.
Since IPO, $2.6 billion has been returned to shareholders, among the highest in the sector.
Financial highlights
Q2 2025 adjusted EBITDA margin was 31% overall and 38% for own-produced volumes; H1 2025 margin was 35% overall and 42% for own-produced volumes.
Net debt as of June 30, 2025, was $909 million, with net debt/EBITDA at 1x.
Free cash flow before growth CapEx in H1 2025 was $307 million, up from $225 million in H1 2024; Q2 2025 free cash flow was $94 million, up 35% year-over-year.
Total cash capital expenditures including growth CapEx were $66 million in H1 2025, with $49 million for maintenance.
Gross profit for H1 2025 was $362.8 million, up from $296.7 million year-over-year.
Outlook and guidance
Near-term nitrogen fertilizer outlook remains favorable, with tight urea and ammonia markets and strong demand from India, Australia, and Brazil.
Maintenance CapEx for 2025 expected at the lower end of $145–$170 million guidance.
Management targets $15–$21 million in cost savings by year-end, supported by ADNOC.
Long-term strategy aims for $1 billion+ EBITDA by 2030 at 2024 prices, anchored on operational excellence, customer proximity, product expansion, and low-carbon growth.
Directors confirm adequate resources for at least 12 months from approval date, supporting a going concern basis.
Latest events from Fertiglobe
- 2025 saw record growth in revenue, EBITDA, and shareholder returns amid tight nitrogen markets.FERTIGLB
Q4 202511 Feb 2026 - Lower H1 2024 earnings amid market headwinds, but cash flow and low-carbon projects advanced.FERTIGLB
Q2 20242 Feb 2026 - Q3 revenue and profit fell, but ADNOC's project transfers will double ammonia capacity by 2029.FERTIGLB
Q3 202415 Jan 2026 - 2024 profit fell, but cost savings and shipment deferrals set up a stronger 2025.FERTIGLB
Q4 202429 Dec 2025 - Q1 2025 revenue up 26%, EBITDA up 45%, ADNOC holds 86.2%, $1B+ EBITDA 2030 targeted.FERTIGLB
Q1 2025 & CMD20 Nov 2025 - Q3 2025 saw strong revenue, EBITDA, and profit growth, with robust capital returns and outlook.FERTIGLB
Q3 202510 Nov 2025